# Long-Term Follow-Up Safety Study of Subjects Treated with SynKIR-110 in Cancer Studies

> **NCT06377202** · — · WITHDRAWN · sponsor: **Verismo Therapeutics**

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06377202
- **Lead sponsor:** Verismo Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-11-15
- **Primary completion:** 2038-12-15
- **Final completion:** 2038-12-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study is being withdrawn and replaced by a new multicenter LTFU Basket Study, designed to monitor the long-term safety of all SynKIR CAR T cell products. This updated study will include all participants who have been treated with Verismo Therapeu
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06377202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06377202, "Long-Term Follow-Up Safety Study of Subjects Treated with SynKIR-110 in Cancer Studies". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06377202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*